Andrea Jarisch

8PUBLICATIONS
28CO-AUTHORS
HaematologyCardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 01, 2024
The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/β-thalassaemia and no or low HbA expression.

Pierre Allard, Laura Tagliaferri, Vivienn Weru

|Feb 07, 2024
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression.

Barbara Meissner, Peter Lang, Peter Bader

|Sep 07, 2023
Response to Haspel and McKenna 'Major incompatible red blood cell transfusions prior to bone marrow transplantation: Not worth the risk'.

Andrea Jarisch, Halvard Bonig

|Mar 23, 2023
Donor-type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors.

Andrea Jarisch, Emilia Salzmann-Manrique, Jan Soerensen

|Jan 06, 2023
CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany.

Peter Bader, Claudia Rossig, Martin Hutter

|Apr 07, 2022
SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination.

Andrea Jarisch, Eliza Wiercinska, Shabnam Daqiq-Mirdad

Pageof 2

Frequent Collaborators

2 joint publications

Peter Bader

2 joint publications

Halvard Bonig

2 joint publications

Roland Meisel

2 joint publications

Ingo Müller